Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines

Manuela Lemoine, Enrico Derenzini, Daniela Buglio, L. Jeffrey Medeiros, R. Eric Davis, Jiexin Zhang, Yuan Ji, Anas Younes

Blood (2012) 119 (17): 4017–4025.

https://doi.org/10.1182/blood-2011-01-331421

Published: 2012

Includes: Supplemental data

Journal Articles

The Small Molecule JAK1/JAK2 Inhibitor INCB16562 Shows Single Agent Activity and Strongly Synergizes with Bcl-2 Inhibitors in Lymphoma

Enrico Derenzini, MD, Manuela Lemoine, PhD, Elisa Brighenti, PhD, Richard Eric Davis, MD, Pier Luigi Zinzani, MD, Anas Younes, MD

Blood (2011) 118 (21): 2731.

https://doi.org/10.1182/blood.V118.21.2731.2731

Published: 2011

Journal Articles

The Allosteric AKT Inhibitor MK-2206 Demonstrates Potent Antiproliferative Activity in Lymphoma Cells and Synergizes with the HDAC Inhibitor Vorinostat,

Daniela Buglio, MD, PhD, Manuela Lemoine, PhD, Jaymie Estrella, PhD, Sattva S. Neelapu, MD, Richard Eric Davis, MD, Laurence Doyle, MD, Richard F Little, MD, MPH, Donald Berry, Anas Younes, MD

Blood (2011) 118 (21): 3729.

https://doi.org/10.1182/blood.V118.21.3729.3729

Published: 2011

Journal Articles

NVP-BEZ235, A Dual Inhibitor of Phosphoinositol-3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), Is a Potent Inhibitor of Lymphoma Cell Growth and Survival

Daniela Buglio, MD, PhD, Manuela Lemoine, PhD, Sattva S. Neelapu, MD, Francisco Vega, MD, PhD, Donald Berry, Anas Younes, MD

Blood (2011) 118 (21): 4965.

https://doi.org/10.1182/blood.V118.21.4965.4965

Published: 2011

Journal Articles

The Pan-Deacetylase Inhibitor Panobinostat Downregulates HIF-1α and VEGF and, Synergizes with Everolimus In Hodgkin Lymphoma Cell Lines

Manuela Lemoine, PhD, Daniela Buglio, MD, PhD, Adam Jona, Enrico Derenzini, MD, L. Jeffrey Medeiros, MD, Donald A Berry, PhD, Anas Younes, MD

Blood (2010) 116 (21): 2851.

https://doi.org/10.1182/blood.V116.21.2851.2851

Published: 2010

NARROW

The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines

The Small Molecule JAK1/JAK2 Inhibitor INCB16562 Shows Single Agent Activity and Strongly Synergizes with Bcl-2 Inhibitors in Lymphoma

The Allosteric AKT Inhibitor MK-2206 Demonstrates Potent Antiproliferative Activity in Lymphoma Cells and Synergizes with the HDAC Inhibitor Vorinostat,

NVP-BEZ235, A Dual Inhibitor of Phosphoinositol-3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), Is a Potent Inhibitor of Lymphoma Cell Growth and Survival

The Pan-Deacetylase Inhibitor Panobinostat Downregulates HIF-1α and VEGF and, Synergizes with Everolimus In Hodgkin Lymphoma Cell Lines

Email alerts

ASH Publications

American Society of Hematology

The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines

The Small Molecule JAK1/JAK2 Inhibitor INCB16562 Shows Single Agent Activity and Strongly Synergizes with Bcl-2 Inhibitors in Lymphoma

The Allosteric AKT Inhibitor MK-2206 Demonstrates Potent Antiproliferative Activity in Lymphoma Cells and Synergizes with the HDAC Inhibitor Vorinostat,

NVP-BEZ235, A Dual Inhibitor of Phosphoinositol-3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), Is a Potent Inhibitor of Lymphoma Cell Growth and Survival

The Pan-Deacetylase Inhibitor Panobinostat Downregulates HIF-1α and VEGF and, Synergizes with Everolimus In Hodgkin Lymphoma Cell Lines

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only